Download PDF
Viszeralchirurgie 2002; 37(5): 340-344
DOI: 10.1055/s-2002-34280
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Palliative onkologische Chirurgie am oberen Verdauungstrakt - Stellenwert in Zeiten multimodaler Therapiekonzepte?

Palliative Surgical Treatment of Upper Gastrointestinal Malignancies - Significance in Times of Multimodal Therapeutic ConceptsA.  H.  Hölscher1 , K.  T. E.  Beckurts1 , P.  M.  Schneider1 , R.  Metzger1
  • 1Klinik und Poliklinik für Viszeral- und Gefäßchirurgie der Universität zu Köln
Further Information

Publication History

Publication Date:
23 September 2002 (online)

    Permissions and Reprints

Zusammenfassung

Der Stellenwert palliativer Chirurgie bei Tumoren des oberen Gastrointestinaltraktes wird in erster Linie relativiert durch endoskopische und perkutan interventionelle Verfahren. Damit kann bei Ösophagus-, Pankreas- und Gallengangskarzinomen in der überwiegenden Mehrzahl der Patienten eine gute Palliation mit niedrigem Risiko erreicht werden. Die Indikation zur palliativen Resektion ist beim Magenkarzinom weiter zu stellen, da das perioperative Risiko geringer ist und die palliativen Effekte bei Blutung, Stenose, Tumorzerfall und Perforation insbesondere bei einer Lebenserwartung von noch ca. 6 Monaten besser sind. Die neoadjuvante Radio-/Chemotherapie verändert den Wert der palliativen Chirurgie bei oben genannten Tumoren nur in dem Maße wie die lokale R0-Resektionsrate gesteigert werden kann. Diese Effekte sind zur Zeit beim Ösophaguskarzinom am deutlichsten. Bis erfolgreiche kurative Behandlungen für Patienten mit fortgeschrittenen Tumoren verfügbar sind, müssen palliative Verfahren weiter verbessert und adäquat angewendet werden.

Abstract

The significance of palliative surgery for tumors of the upper gastrointestinal tract is mainly restricted by endoscopic and percutaneous interventional procedures. By these means a good palliation with low risk can be achieved in the majority of patients with oesophageal, pancreatic and biliary carcinomas. In gastric cancer the indication for palliative resection is more extensive because the perioperative risk is lower and the palliative effects in case of bleeding, stenosis, tumor necrosis and perforation especially for patients with a life expectancy of about 6 months are more favourable. Neoadjuvant radio-/chemotherapy changes the significance of palliative surgery in upper GI-tumors only to the extent that the local R0-resection rate can be increased. Currently these effects are most significant in oesophageal cancer. Until effective treatments for advanced staged patients become available, palliative procedures must be further improved and appropriately implemented.

Schlüsselwörter

Palliative Chirurgie - oberer Verdauungstrakt - Malignome - multimodale Krebstherapie

Key words

Palliative treatment - oncologic surgery - upper gastrointestinal tract - multimodal cancer therapy

Literatur

  • 1 Hölscher A H. Das Radikalitätsprinzip in der operativen Therapie solider Tumoren des Gastrointestinaltraktes. Beger HG, Schwarz A, Brückner UB, Hartel W Forschung in der Chirurgie. Springer, Berlin - Heidelberg - New York 1997: 115-125
    Google Scholar
  • 2 Siewert J R. Praxis der Visceralchirurgie. Onkologische Chirurgie. Springer, Berlin - Heidelberg - New York 2001
    Google Scholar
  • 3 Hölscher A H, Metzger R, Schneider P M. Präoperative Radiochemotherapie des Ösophaguskarzinoms - Licht am Ende des Tunnels?.  Zentralbl Chir. 2000;  125 319-325
    PubMedGoogle Scholar
  • 4 Aulbert E, Zech D. Lehrbuch der Palliativmedizin. Schattauer Verlag, Stuttgart - New York 1997
    Google Scholar
  • 5 Rice D, Geller A, Benda C E, Gostout C J, Donohue J H. Surgical and interventional palliative treatment of upper gastrointestinal malignancies.  Eur J Gastroenterol Hepatol. 2000;  12 403-408
    PubMedGoogle Scholar
  • 6 Kubba A K, Grasner N. An update in the palliative management of malignant dysphagia.  Eur J Surg Oncol. 2000;  26 116-129
    CrossrefPubMedGoogle Scholar
  • 7 Lerut T, de Leyn P, Coosemans W, van Raemdonck D, Cuypers P, van Cleyenbreughel B. Advanced esophageal cancer.  World J Surg. 1994;  18 379-387
    CrossrefPubMedGoogle Scholar
  • 8 Cox J, Bennett J R. Light at the end of the tunnel? Palliation for esophageal carcinoma.  Gut. 1987;  28 781-785
    PubMedGoogle Scholar
  • 9 Segalin A, Little A G, Ruol A, Ferguson M K, Bardini R, Norberto L. et al . Surgical and endoscopic palliation of esophageal carcinoma.  Ann Thor Surg. 1989;  48 267-271
    PubMedGoogle Scholar
  • 10 Pichelmaier H, Krüger I. Palliative allgemeinchirurgische Eingriffe. Aulbert E, Zech D Lehrbuch der Palliativmedizin. Schattauer Verlag, Stuttgart - New York 1997: 175-194
    Google Scholar
  • 11 Gall C A, Rieger N A, Wattchow D A. Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: effect on survival and symptom recurrence.  Aust NZ J Surg. 1996;  66 734-737
    PubMedGoogle Scholar
  • 12 Meijer S, de Bakker O JGB, Hoitsma H FW. Palliative resection in gastric cancer.  J Surg Oncol. 1983;  23 77-80
    CrossrefPubMedGoogle Scholar
  • 13 Ekbom G A, Gleysteen J J. Gastric malignancy: resection for palliation.  Surgery. 1980;  88 476-481
    PubMedGoogle Scholar
  • 14 Haugstveldt T, Viste A, Eide G E, Real C, Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience.  World J Surg. 1989;  13 617-622
    CrossrefPubMedGoogle Scholar
  • 15 Bonzetti F, Bonfanti G, Audisio R A, Doci R, Dossena G, Gennari L, Andreola S. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach.  Surg Gyn Obstet. 1987;  164 151-154
    PubMedGoogle Scholar
  • 16 Butler J, Dubrow T J, Trezona T, Klassen M, Nejdt R J. Total gastrectomy in the treatment of advanced gastric cancer.  Am J Surg. 1989;  159 602-605
    PubMedGoogle Scholar
  • 17 Monson J RT, Donohue J H, Mac Illrath D C, Farnell M B, Ilstrup D M. Total gastrectomy for advanced cancer.  Cancer. 1991;  68 1863-1868
    CrossrefPubMedGoogle Scholar
  • 18 Hallissey M T, Allum W H, Roginski C, Fielding J WL. Palliative surgery for gastric cancer.  Cancer. 1988;  62 440-444
    PubMedGoogle Scholar
  • 19 Adachi Y, Mori M, Maehara Y, Matsumata T, Okudaira Y, Sugimachi K. Surgical results of perforated gastric carcinoma: an analysis of 155 Japanese patients.  Am J Gastroenterol. 1997;  92 516-518
    PubMedGoogle Scholar
  • 20 Gertsch P, Chow L WC, Yuen S T, Chau K Y, Lauder U. Long-term survival after gastrectomy for advanced bleeding or perforated gastric carcinoma.  Eur J Surg. 1996;  162 723-727
    PubMedGoogle Scholar
  • 21 Bonenkamp J J, Sasako M, Hermanns J, van de Velde C JH. Tumor load and surgical palliation in gastric cancer.  Hepatogastroenterol. 2001;  48 1219-1221
    PubMedGoogle Scholar
  • 22 Sugarbaker P H, Yonemura Y. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis.  Hepatogastroenterol. 2001;  48 1238-1247
    PubMedGoogle Scholar
  • 23 Miyamoto M, Sudo T, Kuyama T. Spontaneous rupture of hepatocellular carcinoma: a review of 172 Japanese cases.  Am J Gastroenterol. 1991;  86 67-71
    PubMedGoogle Scholar
  • 24 Lai E CS, Wu K M, Choi T K, Fan S T, Wong J. Spontaneous rupture in hepatocellular carcinoma.  Ann Surg. 1989;  210 24-28
    PubMedGoogle Scholar
  • 25 Xu H S, Yan J B. Concervative management of spontaneous ruptured hepatocellular carcinoma.  Am Surg. 1994;  60 629-633
    PubMedGoogle Scholar
  • 26 Majno P E, Adam R, Bismuth H. Influence of preoperative transarterial lipiodol chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.  Ann Surg. 1998;  226 688-692
    PubMedGoogle Scholar
  • 27 Guthrie C M, Haddock G, de Beaux A C, Garden O J, Carter D C. Changing trends in the management of extrahepatic cholangiocarcinoma.  Br J Surg. 1993;  80 1434-1439
    PubMedGoogle Scholar
  • 28 Lillemoe K D, Pitt H A, Kaufman S L, Cameron J L. Acute cholecystitis: a complication of percutaneous transhepatic drainage.  Surg Gyn Obstet. 1989;  168 348-352
    PubMedGoogle Scholar
  • 29 Beckurts K TE, Hölscher A H, Bauer T, Siewert J R. Maligne Tumoren der Hepatikusgabel - Ergebnisse der chirurgischen Therapie und Prognosefaktoren.  Chirurg. 1997;  68 378-384
    CrossrefPubMedGoogle Scholar
  • 30 Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer.  World J Surg. 1988;  12 39-47
    CrossrefPubMedGoogle Scholar
  • 31 Reding R, Buard J L, Lebeau G, Launois B. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded).  Ann Surg. 1991;  213 236-241
    PubMedGoogle Scholar
  • 32 Washburn K, Lewis W D, Jenkins R L. Aggressive surgical resection for cholangiocarcinoma.  Arch Surg. 1995;  130 270-276
    PubMedGoogle Scholar
  • 33 Kosuge T, Yamanota J, Shimada K. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.  Ann Surg. 1999;  230 663-671
    CrossrefPubMedGoogle Scholar
  • 34 McMasters K M, Tuttle T M, Leach S D. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.  Am J Surg. 1997;  98 752-759
    PubMedGoogle Scholar
  • 35 Watanapa P, Williamson R CN. Surgical palliation for pancreatic cancer: developments during the past two decades.  Br J Surg. 1992;  79 8-20
    CrossrefPubMedGoogle Scholar
  • 36 Potts J R, Broughan T A, Hermann P E. Palliative operations for pancreatic cancer.  Am J Surg. 1990;  159 72-78
    PubMedGoogle Scholar
  • 37 Targarona E M, Pera M I, Martinez J, Balague C, Trias M. Laparoscopic treatment of pancreatic disorders: diagnosis and staging, palliation of cancer and treatment of pancreatic pseudocysts.  Int Surg. 1996;  81 1-5
    PubMedGoogle Scholar
  • 38 Sarfehy U, Rypins E B, Jakowatz J G, Juler G L. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy.  Am J Surg. 1988;  155 411-414
    PubMedGoogle Scholar
  • 39 Bakkevold K E, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery.  Ann Surg. 1993;  217 356-368
    CrossrefPubMedGoogle Scholar
  • 40 Huguier M, Baumel H, Manderscheid J C, Houry S, Fabre J M. Surgical palliation for unresected cancer of the exocrine pancreas.  Eur J Surg Oncol. 1993;  19 342-347
    PubMedGoogle Scholar
  • 41 Bajetta E, di Bartholomeo M, Stani S C. Chemoradiotherapy vs preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study.  Int J Radiat Oncol Biol Phys. 1999;  45 285-289
    PubMedGoogle Scholar
  • 42 Spitz F R, Abbruzzese J L, Lee J E. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.  J Clin Oncol. 1997;  15 928-937
    PubMedGoogle Scholar

Prof. Dr. A. H. Hölscher

Klinik und Poliklinik für Viszeral- und Gefäßchirurgie der Universität zu Köln


Joseph-Stelzmann-Str. 9

50931 Köln

Phone: 0221/478-4801

Fax: 0221/478-4843

Email: Arnulf.Hoelscher@medizin.uni-koeln.de